It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2009.
2009 | Nagpur, Maharashtra, India | ActiveDesert Pharma Private Limited, a active private limited company, was established on 04 March 2009 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2009PTC190697. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.90 M.
It upholds a compliant status. Its leadership includes Nitin Murlidhar Agrawal (Director), Murlidhar Suganchand Agrawal (Director). Past directors included Gamna Ram, Manohar Das, Suparas Bhandari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D-3, Paithankar Road, Itwari Anaj Bazar, Nagpur, Maharashtra, 440002.
U24100MH2009PTC190697
190697
04 March 2009
₹2.50 M
₹1.90 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Desert Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Murlidhar Agrawal | Director | 02 May 2013 | Current |
| Murlidhar Suganchand Agrawal | Director | 02 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Sep 2012 | Past |
| Pramod Abcsdd | Director | 03 Sep 2012 | Past |
| Pramod Abcsdd | Director | 03 Oct 2012 | Past |
| Pramod Abcsdd | Director | 18 Jul 2013 | Past |
| Pramod Abcsdd | Director | 19 Jul 2011 | Past |
| Pramod Abcsdd | Director | 19 Jul 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Desert Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.21% increase in profit. The company's net worth dipped by a decrease of 0.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2020, Desert Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Desert Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Desert Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Desert Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Desert Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Desert Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Nitin Murlidhar Agrawal was appointed as a Director was appointed as a Director on 02 May 2013 & has been associated with this company since 12 years 7 months . was documented.
Murlidhar Suganchand Agrawal was appointed as a Director was appointed as a Director on 02 May 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.
The activity Desert Pharma Private Limited was registered on 04 Mar 2009 with Roc Mumbai & aged 16 years 9 months as per MCA records. was completed.
The CIN of Desert Pharma Private Limited is U24100MH2009PTC190697.
Desert Pharma Private Limited is headquartered at D-3, Paithankar Road, Itwari Anaj Bazar, Nagpur, Maharashtra, 440002.
Desert Pharma Private Limited was incorporated on 04 March 2009.
The current directors of Desert Pharma Private Limited are
The primary industry of Desert Pharma Private Limited is Trade.
Desert Pharma Private Limited is unlisted.
The authorized capital of Desert Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.90 M.
The compliance status of Desert Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX